Charming Medical Limited (MCTA)
NASDAQ · Healthcare
Charming Medical Limited Revenue 2023–2025
Charming Medical Limited annual/quarterly revenue history and growth rate from 2023 to 2025. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Charming Medical Limited annual revenue for 2025 was 6.2 M, a 3.43% increase from 2024.
- Charming Medical Limited annual revenue for 2024 was 6.0 M, a 70.37% increase from 2023.
- Charming Medical Limited annual revenue for 2023 was 3.5 M.
No data available.
Charming Medical Limited (MCTA) — Frequently Asked Questions
Charming Medical Limited (MCTA) is a publicly traded US company. In fiscal 2025 it reported revenue of $6M and net income of $1M. Explore MCTA's stock price, financial statements, earnings history, margins and key ratios below.
What is the MCTA stock price?
MCTA trades at $29.36.
How much revenue does Charming Medical Limited make?
Charming Medical Limited reported revenue of $6M in fiscal 2025.
Is MCTA profitable?
In fiscal 2025, Charming Medical Limited reported net income of $1M.